Menu
  • Home
  • About Us
    • About 340B Report
    • Who We Are
    • Testimonials
    • Work With 340B Report
    • Contact
  • Subscribe Now
  • Document Center
  • Expert Directory
  • Events Calendar
  • Industry Insights
  • Sponsor/Advertise
  • Sign in
340B Report

340B Report

Category: Pharma Industry

BREAKING: Bipartisan Group of 217 U.S. Representatives Ask HHS to Stop 340B Rebate Model and Look Into Third Party Vendors

In Breaking, Federal, Legislative, Other Industry, Pharma Industry, RegulatoryNovember 13, 2020 Tom Mirga
…
Read More »

BREAKING: Novartis Retreats, But Not Entirely, on 340B Contract Pharmacy (Update 2)

In Breaking, Federal, Pharma Industry, RegulatoryOctober 30, 2020 Tom Mirga

Novartis Retreats, But Not Entirely, on 340B Contract Pharmacy (Update 2)

Update 2, Friday Oct. 30, 4:00 p.m. EDT—Hospital group 340B Health said Novartis’ action was inexcusable. “The

…
Read More »

EXCLUSIVE: Lilly’s Letter to HRSA on Why it Thinks 340B Contract Pharmacy is Unlawful

In Federal, Pharma Industry, RegulatoryOctober 30, 2020 Tom Mirga

Lilly’s Letter to HRSA on Why it Thinks 340B Contract Pharmacy is Unlawful

Drug manufacturer Eli Lilly and Co. on May 18 gave the U.S. Health Resources and

…
Read More »

Iowa’s U.S. Senators Meet With HHS Top Brass About Pharma’s 340B Moves

In Federal, Legislative, Pharma Industry, RegulatoryOctober 27, 2020 Tom Mirga

Iowa’s U.S. senators—Chuck Grassley and Joni Ernst, both Republicans—met with top HHS officials yesterday to relay Iowa hospitals’ concerns about pharmaceutical manufacturers’ recent denials of 340B pricing
…
Read More »

BREAKING: Health Centers Sue HHS Over Drug Company Denials of 340B Pricing

In Breaking, Federal, Judicial, Pharma Industry, Regulatory, Trade AssociationOctober 21, 2020 Tom Mirga

Health Centers Sue HHS Over Drug

…
Read More »

HIV/AIDS Activists March To Protest AstraZeneca’s 340B Contract Pharmacy Cutbacks

In Federal, Non-Governmental, Pharma Industry, RegulatoryOctober 15, 2020 Tom Mirga
SPONSORED BY


…

Read More »

Sanofi Reportedly Is Not Providing Some Promised 340B Pricing

In Federal, Pharma Industry, RegulatoryOctober 13, 2020 Tom Mirga
SPONSORED BY


…

Read More »

BREAKING: HIV/AIDS Clinics Sue HHS Over Drug Manufacturers’ Denials of 340B Pricing

In Breaking, Federal, Judicial, Pharma Industry, Regulatory, Trade AssociationOctober 10, 2020 Tom Mirga

HIV/AIDS Clinics Sue HHS Over Drug

…
Read More »

More than Half of Health Care Industry Execs Expect 340B Reporting Requirements Within Five Years

In Legislative, Other Industry, Pharma Industry, Regulatory, Research/ReportsOctober 8, 2020 Tom Mirga
SPONSORED BY


A

…
Read More »

BREAKING: Connecticut Attorney General Demands Five Manufacturers Cease 340B Actions

In Breaking, Federal, Pharma Industry, Regulatory, StateOctober 6, 2020 Tom Mirga
SPONSORED BY


A

…
Read More »

Posts navigation

1 2 3 4 5 … 7

Site Sidebar

Categories

  • Breaking
  • Federal
  • Judicial
  • Legislative
  • Non-Governmental
  • Other Industry
  • Pharma Industry
  • Regulatory
  • Research/Reports
  • State
  • Trade Association
  • Uncategorized

Recent Posts

  • Our First Issue Behind Our Paywall
  • Gilead Adjusts Planned Change in its Patient Assistance After HIV Community Pushes Back
  • HHS Asks Court to Toss Out Hospitals’ 340B Contract Pharmacy Lawsuit
  • View From Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program
  • Senate Finance Report Might Shed Light on Insulin Manufacturers’ 340B Contract Pharmacy Actions

Site Footer

Terms of Use Privacy Policy